Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elevance HealthELV +0.07%89 5-Year Yield-on-Cost % is 3.33 as of Jul. 17, 2026, which is 54% above its 10-year median of 2.16. GuruFocus rates ELV with a GF Score™ of 89/100 and a GF Value™ of $490.84 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 9 Healthcare Plans companies, Elevance Health ranks worse than 55.56% on this metric.
Elevance Health's yield on cost for the quarter that ended in Jun. 2026 was 3.33.
The historical rank and industry rank for Elevance Health's 5-Year Yield-on-Cost % or its related term are showing as below:
ELV'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.64 Med: 2.16 Max: 4.42
Current: 3.33
During the past 13 years, Elevance Health's highest Yield on Cost was 4.42. The lowest was 1.64. And the median was 2.16.
ELV's 5-Year Yield-on-Cost % is ranked worse than 55.56% of 9
companies
in the Healthcare Plans industry
Industry Median: 3.35
vs ELV: 3.33
Elevance Health (NYSE:ELV) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Elevance Health 5-Year Yield-on-Cost % Related Terms
ELV vs CI, HUM, CVS: 5-Year Yield-on-Cost % Comparison
For the Healthcare Plans subindustry, Elevance Health's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health 5-Year Yield-on-Cost % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Elevance Health's 5-Year Yield-on-Cost % falls into.
Elevance Health 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Elevance Health is calculated as
Elevance Health (ELV) has a 5-Year Yield-on-Cost % of 3.33 as of Jul. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Elevance Health and its competitors. This is 54% above median its historical median of 2.16. Over the past decade, Elevance Health's 5-Year Yield-on-Cost % has ranged from 1.64 to 4.42. According to the industry distribution chart, Elevance Health ranks #5 out of 9 companies in the Healthcare Plans industry, placing it in the top 55.6%.
Is Elevance Health's 5-Year Yield-on-Cost % too high?
Elevance Health's current 5-Year Yield-on-Cost % of 3.33 is 54% above median its 10-year median of 2.16. Over the past 10 years, this metric has ranged from a low of 1.64 to a high of 4.42. The Healthcare Plans industry median 5-Year Yield-on-Cost % is 3.35. Elevance Health's value of 3.33 is 0.6% below this industry median. Based on the distribution chart, Elevance Health ranks #5 out of 9 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Elevance Health has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's 5-Year Yield-on-Cost % compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #5 out of 9 companies for 5-Year Yield-on-Cost %. This places Elevance Health in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.35. Elevance Health's value of 3.33 is 0.6% below this benchmark. Historically, Elevance Health's own 5-Year Yield-on-Cost % has ranged from 1.64 to 4.42 over the past decade. While the company's 10-year median is 2.16 vs. the industry median of 3.35, Elevance Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Plans company?
The median 5-Year Yield-on-Cost % among Healthcare Plans companies is 3.35, based on 9 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current 5-Year Yield-on-Cost % of 3.33 is 0.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median 5-Year Yield-on-Cost % is 3.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current 5-Year Yield-on-Cost % is 3.33, which is 54% above median its own 10-year median of 2.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is $490.84, compared to a current price of $373.11 — trading 24% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.33, which is 54% above median its 10-year median of 2.16 and 0.6% below the Healthcare Plans industry median of 3.35. Elevance Health's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Elevance Health (ELV), the current 5-Year Yield-on-Cost % is 3.33 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of $373.11 is trading 24% below its estimated GF Value™ of $490.84.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for ELV:
5-Year Yield-on-Cost %: 3.33 (54% above median its 10-year median of 2.16)
GF Value™: $490.84 vs. price of $373.11 (24% below fair value)
Industry Position: 0.6% below the Healthcare Plans median (#5 of 9)
No single metric tells the full story. See the ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
89GF Score
Get the complete analysis for ELV
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELV has been successfully added to your 
